Oncaspar and cerebrovascular accident Patient Reports February 11, 2012

Oncaspar Side Effects Report #4628315-2
Oncaspar side effect was reported by a Health Professional from on Mar 18, 2005. Male patient, child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: cerebrovascular accident. Oncaspar dosage: unknown. During the same period patient was treated with VINCRISTINE, NYSTATIN, BACTRIM. Patient was hospitalized. Patient recovered.

Oncaspar Side Effects Report #4801754-2
Oncaspar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2005. Female patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hepatic failure, pancreatitis. Oncaspar dosage: unknown. Patient died.

Oncaspar Side Effects Report #4807413-4
Oncaspar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2005. Female patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: cerebrovascular accident, hepatic failure, pancreatitis. Oncaspar dosage: unknown. Patient died.

Oncaspar Side Effects Report #6035060-8
Oncaspar side effect was reported by a Consumer or non-health professional from CANADA on Jan 04, 2009. Male patient, 14 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: cerebrovascular accident. Oncaspar dosage: 2400 MG/M**2; IM. Patient recovered.


Oncaspar Side Effects Report #5664088-2
Oncaspar side effect was reported by a Physician from UNITED STATES on Feb 28, 2008. Female patient, weighting 31.31 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Oncaspar. After drug was administered, patient experienced the following side effects: antithrombin iii decreased, cerebral artery occlusion, cerebral ischaemia, cerebrovascular accident, protein s decreased. Oncaspar dosage: unknown. During the same period patient was treated with CEFTAZIDIME, PREDNISONE, PEPCID, DIFLUCAN, BACTRIM. Patient was hospitalized. Patient recovered.